KLF4, negatively regulated by miR-7, suppresses osteoarthritis development via activating TGF-β1 signaling

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Osteoarthritis (OA) is a debilitating chronic degenerative joint disease impacting millions worldwide.
• Previous research identified miR-7 overexpression in OA, suggesting its role in disease pathogenesis, but the precise molecular mechanisms were unclear.
• Understanding the molecular regulators of OA is crucial for developing effective therapeutic strategies.

Purpose of the Study:

• To elucidate the molecular mechanism by which miR-7 contributes to osteoarthritis development.
• To identify the direct target gene of miR-7 involved in OA pathogenesis.
• To investigate the therapeutic potential of targeting the miR-7/KLF4 axis in OA.

Main Methods:

• Dual luciferase reporter assay to confirm KLF4 as a direct target of miR-7.
• Quantitative real-time PCR (qRT-PCR) and Western blot to assess gene and protein expression levels.
• In vivo studies using rat OA models with histological analysis (HE and Safranin O-Fast green staining, immunohistochemistry).

Main Results:

• KLF4 was identified as a direct target of miR-7 and was significantly downregulated in human OA tissues and chondrocytes.
• miR-7 negatively regulates KLF4 expression, while KLF4 overexpression increased beneficial cartilage-specific genes (SOX9, COL2A1) and decreased detrimental ones (RUNX2, MMP13).
• KLF4 activated the TGF-β1 signaling pathway, influencing OA progression, and its restoration reversed miR-7's detrimental effects on OA chondrocytes and improved OA in a rat model.

Conclusions:

• KLF4 acts as a tumor suppressor in osteoarthritis, counteracting the pro-degenerative effects of miR-7.
• Targeting the miR-7/KLF4 interaction presents a promising therapeutic avenue for osteoarthritis treatment.
• This study provides a deeper mechanistic understanding of OA pathogenesis involving miR-7 and KLF4.